Balyasny Asset Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58M Buy
556,374
+424,312
+321% +$2.21M ﹤0.01% 1675
2025
Q4
$660K Sell
132,062
-123,281
-48% -$642K ﹤0.01% 2391
2025
Q3
$1.29M Buy
255,343
+234,320
+1,115% +$1.03M ﹤0.01% 2010
2025
Q2
$90.6K Buy
+21,023
New +$104K ﹤0.01% 2691
2025
Q1
Sell
-1,234,759
Closed -$4.88M 3118
2024
Q4
$4.88M Sell
1,234,759
-590,368
-32% -$2.64M 0.01% 1301
2024
Q3
$10.7M Sell
1,825,127
-1,044,707
-36% -$5.15M 0.02% 915
2024
Q2
$12.4M Buy
2,869,834
+2,725,005
+1,882% +$13.1M 0.02% 790
2024
Q1
$681K Sell
144,829
-3,932,900
-96% -$15.1M ﹤0.01% 1940
2023
Q4
$20M Sell
4,077,729
-1,413,318
-26% -$6.92M 0.04% 604
2023
Q3
$29.9M Sell
5,491,047
-1,592,701
-22% -$12.8M 0.06% 429
2023
Q2
$65.6M Buy
7,083,748
+2,841,987
+67% +$24M 0.14% 187
2023
Q1
$34.9M Sell
4,241,761
-3,329,651
-44% -$36.8M 0.09% 320
2022
Q4
$84.3M Buy
7,571,412
+3,572,281
+89% +$41.5M 0.23% 95
2022
Q3
$47.4M Sell
3,999,131
-592,488
-13% -$8.97M 0.15% 165
2022
Q2
$70.1M Buy
4,591,619
+2,392,230
+109% +$43M 0.23% 89
2022
Q1
$46.5M Buy
2,199,389
+1,842,014
+515% +$39.7M 0.15% 162
2021
Q4
$8.45M Sell
357,375
-1,176,362
-77% -$25.2M 0.03% 685
2021
Q3
$30.8M Buy
+1,533,737
New +$31.4M 0.13% 223
2021
Q2
Sell
-565,174
Closed -$12M 2200
2021
Q1
$12M Buy
565,174
+21,567
+4% +$464K 0.06% 425
2020
Q4
$11.8M Sell
543,607
-148,662
-21% -$2.9M 0.07% 399
2020
Q3
$12.2M Buy
+692,269
New +$12.9M 0.09% 331
2019
Q3
Sell
-406,713
Closed -$7.09M 1424
2019
Q2
$7.09M Buy
+406,713
New +$7.32M 0.05% 503
2019
Q1
Sell
-69,291
Closed -$1.11M 1545
2018
Q4
$1.11M Sell
69,291
-385,035
-85% -$6.09M 0.01% 867
2018
Q3
$6.77M Buy
454,326
+428,914
+1,688% +$6.26M 0.03% 603
2018
Q2
$357K Sell
25,412
-274,331
-92% -$3.63M ﹤0.01% 1457
2018
Q1
$3.9M Sell
299,743
-466,305
-61% -$5.97M 0.02% 782
2017
Q4
$10.6M Buy
+766,048
New +$10.4M 0.03% 620
2017
Q3
Sell
-1,220,715
Closed -$15.7M 2017
2017
Q2
$15.7M Buy
+1,220,715
New +$16.3M 0.06% 390
2017
Q1
Sell
-1,789,004
Closed -$22M 1717
2016
Q4
$22M Buy
1,789,004
+754,424
+73% +$9.76M 0.12% 248
2016
Q3
$15.3M Buy
+1,034,580
New +$15.7M 0.09% 308
2015
Q4
Sell
-141,029
Closed -$1.56M 1364
2015
Q3
$1.56M Buy
+141,029
New +$1.75M 0.01% 691

Other funds holding MPT

Balyasny Asset Management's MPT Position: Q1 2026 in Review

Balyasny Asset Management increased its Medical Properties Trust (MPT) stake by 321% in Q1 2026, buying an estimated $2.21M and bringing the position to 556,374 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Balyasny Asset Management first reported a position in MPT in Q3 2015 and has held it in 31 quarters since. The position peaked at $84.3M in Q4 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Balyasny Asset Management held 556,374 shares of Medical Properties Trust worth $2.58M as of Q1 2026.
  • Balyasny Asset Management bought 424,312 Medical Properties Trust shares in Q1 2026, an estimated $2.21M.
  • Medical Properties Trust made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1675 holding.
  • Balyasny Asset Management first reported a position in Medical Properties Trust in Q3 2015 and has held it in 31 quarters since.
  • Balyasny Asset Management's Medical Properties Trust position peaked at $84.3M in Q4 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.